• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

Recent Advances in the Application of 2-Phenyl-propionyl Chloride (CAS 22414-26-2) in Chemical and Pharmaceutical Research

2-Phenyl-propionyl Chloride (CAS 22414-26-2) is a key intermediate in the synthesis of various pharmaceutical compounds and fine chemicals. Recent studies have highlighted its versatility in organic synthesis, particularly in the formation of esters, amides, and other derivatives that serve as building blocks for drug development. This research brief consolidates the latest findings on the applications, mechanisms, and innovations surrounding this compound, providing a comprehensive overview for professionals in the chemical and pharmaceutical industries.

A significant focus of current research involves the use of 2-Phenyl-propionyl Chloride in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs). Recent publications in journals such as the Journal of Medicinal Chemistry and Organic Letters have demonstrated its efficacy in creating novel NSAID derivatives with improved pharmacokinetic properties. For instance, a 2023 study utilized this compound to develop a series of propionic acid derivatives, showing enhanced selectivity for COX-2 inhibition while minimizing gastrointestinal side effects.

In addition to its pharmaceutical applications, 2-Phenyl-propionyl Chloride has been employed in material science. A breakthrough study published in Advanced Materials (2024) reported its use in the synthesis of polymer coatings with tunable hydrophobicity, which have potential applications in biomedical devices. The compound's reactivity with hydroxyl and amino groups makes it a valuable tool for surface functionalization, enabling the development of smart materials with targeted properties.

Mechanistic insights into the reactions involving 2-Phenyl-propionyl Chloride have also been a subject of recent investigations. Computational chemistry studies, leveraging density functional theory (DFT), have elucidated the energy profiles and transition states of its acylation reactions. These findings, published in The Journal of Physical Chemistry A, provide a deeper understanding of reaction kinetics and selectivity, facilitating the design of more efficient synthetic routes.

From an industrial perspective, advancements in the scalable production of 2-Phenyl-propionyl Chloride have been reported. A 2024 patent application detailed an optimized continuous-flow process that enhances yield and reduces waste compared to traditional batch methods. This innovation addresses growing demand while aligning with green chemistry principles, as highlighted in the patent documentation and related industry reports.

Ongoing clinical research has explored prodrug formulations derived from 2-Phenyl-propionyl Chloride. Phase I trials for a new analgesic prodrug, which utilizes this compound as a promoiety, have shown promising results in terms of bioavailability and controlled release profiles. These developments suggest expanding therapeutic applications in pain management, with further clinical evaluations anticipated in the coming years.

In conclusion, 2-Phenyl-propionyl Chloride (CAS 22414-26-2) continues to be a compound of significant interest across multiple research domains. Its applications span from pharmaceutical synthesis to advanced materials, supported by both experimental and theoretical advancements. The compound's versatility and the recent innovations in its utilization underscore its enduring relevance in chemical and biomedical research, offering numerous opportunities for future developments and applications.

• 35675-44-6(2-(4-methylphenyl)acetyl chloride)
• 5078-73-9(1-Naphthaleneacetyl chloride, a-methyl-)
• 6068-70-8(A,A-Diphenyl-Benzeneacetyl Chloride)
• 1871-76-7(Diphenylacetyl chloride)
• 22063-97-4(9-Anthracenecarbonyl chloride, 9,10-dihydro-)
• 7477-16-9( )
• 34715-60-1(Benzeneacetyl chloride,a-methyl-4-(2-methylpropyl)-)
• 13910-79-7(2-(3-methylphenyl)acetyl chloride)
• 63327-24-2(2-(4-Chlorophenyl)propionyl chloride)
• 6324-62-5(Benzeneacetyl chloride, 2-methyl-a-(2-methylphenyl)-a-phenyl-)